DAVID EMERSON JORDEN

CIK 1313516 · CEO/CFO · last filed 2026-06-05

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

4

Total Filings

162

Lifetime Open-Market Net

$1.59M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
PLx Pharma Inc. (PLXP) Delisted Acting Chief Financial Officer 151,913 $0.09 $13.2K $225.0K 2 2017-06-16
Acer Therapeutics Inc. (OPXAW) Delisted Acting Chief Financial Officer 293,456 $155.3K 24 2013-09-26
ConnectOne Bancorp, Inc. (CNBC) Delisted Director 5,765,000 $29.2K 1 2011-03-09
Nuo Therapeutics, Inc. (GTF) Delisted Director 5,402,858 $1.18M 82 2011-01-26

Recent Filings · Page 6 of 17

162 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2011-03-15 Buy (P) +12,500 $4.9K
2011-03-14 Buy (P) +35,000 $14.0K
2011-03-10 Buy (P) +72,200 $29.2K
2011-03-09 ConnectOne Bancorp, Inc. (CNBC) Delisted Buy (P) +72,200 $29.2K EDGAR
2011-03-08 Buy (P) +72,800 $29.5K
2011-02-22 Buy (P) +13,414 $5.8K
2011-02-18 Buy (P) +41,586 $18.1K
2011-02-15 Buy (P) +12,450 $5.5K
2011-02-15 Buy (P) +15,000 $6.3K
2011-02-14 Buy (P) +27,550 $12.2K
Showing 5160 of 162
Page 6 of 17
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.